Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells-Reference-Cited by-同舟云学术

Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells

Published:2010-06 Issue:6 Volume:17 Page:584-596
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Mullally Ann,Lane Steven W.,Ball Brian,Megerdichian Christine,Okabe Rachel,Al-Shahrour Fatima,Paktinat Mahnaz,Haydu J. Erika,Housman Elizabeth,Lord Allegra M.,Wernig Gerlinde,Kharas Michael G.,Mercher Thomas,Kutok Jeffery L.,Gilliland D. Gary,Ebert Benjamin L.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference61 articles.

1. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias;Abdel-Wahab;Cancer Res.,2010

2. Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease;Akada;Blood,2010

3. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

4. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder;Braun;Proc. Natl. Acad. Sci. USA,2004

5. Mutation of JAK2 in the myeloproliferative disorders: Timing, clonality studies, cytogenetic associations, and role in leukemic transformation;Campbell;Blood,2006

Cited by 321 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clonal hematopoiesis mutation Jak2 aggravates endothelial injury and thrombosis in arteries with erosion-like intimas;International Journal of Cardiology;2024-08

2. IL-1 in aging and pathologies of hematopoietic stem cells;Blood;2024-07-25

3. Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F–positive myeloproliferative neoplasms;Blood;2024-06-13

4. Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia;Journal of Hematology & Oncology;2024-06-09

5. In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms;Blood;2024-06-06